Systematic exploration of the underlying mechanism of gemcitabine resistance in pancreatic adenocarcinoma-Reference-Cited by-同舟云学术

Systematic exploration of the underlying mechanism of gemcitabine resistance in pancreatic adenocarcinoma

Published:2022-07-22 Issue:16 Volume:16 Page:3034-3051
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Liu Kaidong¹,Geng Yiding¹,Wang Linzhu²,Xu Huanhuan¹,Zou Min¹,Li Yawei¹,Zhao Zhangxiang³,Chen Tingting¹,Xu Fengyan²,Sun Liang²,Wu Shuliang²,Gu Yunyan¹^ORCID

Affiliation:

1. Department of Systems Biology, College of Bioinformatics Science and Technology Harbin Medical University Harbin China

2. Department of Human Anatomy, Key Laboratory of Preservation of Human Genetic Resources and Disease Control in China, Ministry of Education Harbin Medical University Harbin China

3. The Sino‐Russian Medical Research Center of Jinan University, the Institute of Chronic Disease of Jinan University The First Affiliated Hospital of Jinan University Guangzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13279

Reference57 articles.

1. Cancer Statistics, 2021

2. Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression

3. Pancreatic Cancer Epidemiology, Detection, and Management